All News

    FDA Approves Hernexeos for Non-Squamous Non-Small Cell Lung Cancer

    August 8th 2025, 5:49pm

    Article

    The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

    A Moment of Kindness I’ll Never Forget During Cancer Treatment

    August 8th 2025, 5:00pm

    Article

    During World Cancer Support Month, I’m remembering a moment in 2012 a group of teachers — especially Mrs. Reed — lifted me up with unexpected kindness.

    Incidence of Early-Onset Liver Cancer in Younger Patients Decreasing

    August 8th 2025, 4:00pm

    Article

    The incidence of hepatocellular carcinoma has risen between 2010 and 2019; however, for people under 50 years of age, the proportion of cases has declined.

    Epkinly Combo Reduces Risk of Progression or Death in Follicular Lymphoma

    August 8th 2025, 3:00pm

    Article

    Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

    How Biomarkers May Help Guide Kidney Cancer Treatment Earlier

    August 8th 2025, 1:00pm

    Video

    Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.

    Please Don’t Call Me ‘Dear’: A Poem From Cancer Treatment

    August 7th 2025, 9:00pm

    Article

    I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.

    Mom Supports Other Parents After Daughter’s Bone Cancer Diagnosis

    August 7th 2025, 7:00pm

    Article

    Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated during the process.

    A Letter to My Support System

    August 7th 2025, 5:00pm

    Article

    I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.

    Zusduri Shows Durable Response in Non–Muscle-Invasive Bladder Cancer

    August 7th 2025, 4:00pm

    Article

    In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.

    AI May Better Predict Cancer Biomarkers and Patient Survival

    August 7th 2025, 3:00pm

    Article

    An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.